Dr. Donghoon Chung's research lab at the University of Louisville focuses on developing new antiviral therapies specifically targeting arthritogenic alphaviruses like Chikungunya. The lab aims to optimize a unique antiviral compound that has shown promise against certain alphaviruses and enhance its effectiveness against other forms of these viruses, which have the potential to cause significant public health challenges. The multidisciplinary team combines efforts in structural biology, medicinal chemistry, and virology to create next-generation antiviral drugs.

Dr. Venkatakrishna Rao Jala's lab focuses on understanding how gut barrier dysfunction contributes to inflammatory bowel diseases (IBD) like ulcerative colitis and Crohn's disease. They are investigating a compound called Urolithin A (UroA), which shows promise in enhancing gut barrier function and reducing inflammation. Their research aims to uncover the mechanisms by which UroA activates specific cellular pathways to provide potential treatments for IBD.

Dr. Matthew Lawrenz's lab at the University of Louisville focuses on understanding how the bacterium Yersinia pestis, which causes plague, interacts with the human immune system. His research investigates how this pathogen alters immune responses and evades inflammation during infection. By studying the mechanisms that Yersinia pestis uses to suppress immune communication and acquire essential nutrients from the host, the lab aims to uncover potential new therapies for plague and improve our understanding of bacterial infection processes.

Dr. Huang-Ge Zhang's lab focuses on understanding how tiny nanoparticles found in edible plants can prevent brain inflammation, which is a key issue in aging and brain diseases. By studying these nanoparticles, called exosome-like nanoparticles (ELNs), the lab aims to uncover their effects on brain immune cells and the potential for developing new dietary interventions to improve brain health. This research could lead to novel strategies for preventing or treating chronic inflammation in the brain.